All In Biotech

Drug Trial Radar · NCT06865105

Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis

A Phase 2 Multicenter, Randomized, Platform Study of Targeted Therapies for the Treatment of Adult Subjects With Active Psoriatic Arthritis

Last checked: Nov 19, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 300 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

300

Planned (sponsor's estimate)

Start

Apr 11, 2025

Primary completion

Aug 2029

Study completion Aug 2029

Sponsor

Lead sponsor
AbbVieAbbVie (ABBV)
Sponsor type
Industry
First posted
Mar 7, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Psoriatic arthritis (PsA) is a type of arthritis that happens when the body's immune system attacks healthy cells and tissues causing joint pain, stiffness, and swelling. Symptoms can get worse and go away for periods of time. This study will evaluate the efficacy and safety of targeted therapies through a series of substudies, for the treatment of active psoriatic arthritis and to assess the changes in disease symptoms. The therapies being assessed in this study are risankizumab, lutikizumab, ABBV-701, and ABBV-547. In Substudy 1, participants will be randomized in a 1:1:1 ratio to one of the three treatment arms: lutikizumab monotherapy, risankizumab monotherapy or a combination therapy of lutikizumab and risankizumab. In Substudy 2, participants will be randomized in a 1:1:1 ratio to one of the three treatment arms: ABBV-701 monotherapy, risankizumab monotherapy, or a combination therapy of ABBV-701 and risankizumab. In Substudy 3, participants will be randomized in a 1:1:1 ratio to one of three doses of ABBV-547. Around 300 participants will be enrolled in the study at approximately 110 sites worldwide.

Conditions

  • Psoriatic Arthritis

Interventions

  • LutikizumabDrug

    Subcutaneous (SC) Injection

  • RisankizumabDrug

    Subcutaneous (SC) Injection

  • ABBV-701Drug

    Subcutaneous (SC) Injection

  • ABBV-547Drug

    Subcutaneous (SC) Injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With an American College of Rheumatology 50% (ACR50) ResponseTime frame: At Week 16
  2. Number of Participants With Adverse Events (AEs)Time frame: Up to Week 52

Locations

41 sites in 6 countries. Site status is shown where the registry gives one.

  • Newport Huntington Medical Group /ID# 272764

    Huntington Beach, California · Recruiting

  • Highlands Advanced Rheumatology And Arthritis Center - Avon Park /ID# 273085

    Avon Park, Florida · Recruiting

  • Clinical Research Of West Florida - Phase I Unit /ID# 273198

    Clearwater, Florida · Recruiting

  • HMD Research LLC /ID# 273086

    Orlando, Florida · Recruiting

  • West Broward Rheumatology Associates /ID# 272892

    Tamarac, Florida · Recruiting

  • Clinical Research Of West Florida - Tampa - North Howard Avenue /ID# 273199

    Tampa, Florida · Recruiting

  • Northwestern Medicine - Northwestern Memorial Hospital /ID# 275469

    Chicago, Illinois · Recruiting

  • Clinic Of Dr. Robert Hozman/Clinical Investigation Specialists, Inc /ID# 272879

    Skokie, Illinois · Completed

  • Willow Rheumatology and Wellness /ID# 277354

    Willowbrook, Illinois · Recruiting

  • Klein & Associates /ID# 272829

    Cumberland, Maryland · Completed

  • Dartmouth-Hitchcock Medical Center /ID# 272702

    Lebanon, New Hampshire · Recruiting

  • Paramount Medical Research and Consulting /ID# 272757

    Middleburg Heights, Ohio · Recruiting

  • Altoona Center For Clinical Research /ID# 272593

    Duncansville, Pennsylvania · Recruiting

  • Private Practice - Dr. Ramesh C. Gupta /ID# 272897

    Memphis, Tennessee · Recruiting

  • Tekton Research - West Gate /ID# 272765

    Austin, Texas · Recruiting

  • Arthritis and Rheumatology Research Institute - Frisco /ID# 277306

    Frisco, Texas · Recruiting

  • Accurate Clinical Research - Houston /ID# 272754

    Houston, Texas · Recruiting

  • Tekton Research, LLC /ID# 272901

    San Antonio, Texas · Recruiting

  • DM Clinical Research - Tomball /ID# 272760

    Tomball, Texas · Recruiting

  • Centre Hospitalier Universite De Sherbrooke - Hotel-Dieu Hospital /ID# 273715

    Sherbrooke, Quebec, Canada · Recruiting

  • Centre de Recherche Musculo-Squelettique /ID# 274397

    Trois-Rivières, Quebec, Canada · Recruiting

  • Dr. Latha Naik Medical Professional Corporation /ID# 272803

    Saskatoon, Saskatchewan, Canada · Recruiting

  • Medical Plus Research /ID# 272363

    Uherské Hradiště, Czechia · Recruiting

  • PV Medical Services /ID# 272368

    Zlín, Czechia · Recruiting

  • Revmatologie /ID# 272367

    Brno, Brno-mesto, Czechia · Recruiting

  • L.K.N. Arthrocentrum /ID# 272366

    Hlučín, Moravian-Silesian Region, Czechia · Recruiting

  • Centre Hospitalier Universitaire de Nice - Hopital Pasteur /ID# 272771

    Nice, Alpes-Maritimes, France · Recruiting

  • Infirmerie Protestante De Lyon /ID# 273731

    Caluire-et-Cuire, Auvergne-Rhône-Alpes, France · Recruiting

  • Centre Hospitalier Regional Universitaire De Tours - Hopital Trousseau /ID# 272762

    Chambray-lès-Tours, Indre-et-Loire, France · Recruiting

  • Centre Hospitalier Regional d Orleans - Hopital de la Source /ID# 272877

    Orléans, Loiret, France · Completed

  • Chu Bordeaux - Hopital Pellegrin /ID# 273390

    Bordeaux, New Aquitaine, France · Completed

  • Semmelweis Egyetem Reumatologiai es Immunologiai Klinika /ID# 273195

    Budapest, Hungary · Recruiting

  • Revita Reumatologiai Rendelo (Revita Kft.) /ID# 272857

    Budapest, Hungary · Recruiting

  • Borsod-Abauj-Zemplen Varmegyei Kozponti Korhaz es Egyetemi Oktatokorhaz /ID# 272572

    Miskolc, Borsod-Abauj Zemplen county, Hungary · Recruiting

  • Complex Rendelo Med Zrt. /ID# 272570

    Székesfehérvár, Fejér, Hungary · Recruiting

  • Vital-Medicina /ID# 272855

    Veszprém, Fejér, Hungary · Recruiting

  • Medicover Integrated Clinical Services - Bydgoszcz (SMO/Network/Consortium) /ID# 273297

    Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland · Recruiting

  • MCBK S.C. Iwona Czajkowska Anna Podrazka-Szczepaniak /ID# 273305

    Pruszków, Masovian Voivodeship, Poland · Recruiting

  • Centrum Medyczne Reuma Park /ID# 273301

    Warsaw, Masovian Voivodeship, Poland · Recruiting

  • Osteo Medic s.c. Artur Racewicz Jerzy Supronik /ID# 273304

    Bialystok, Podlaskie Voivodeship, Poland · Completed

Showing 40 of 41 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.